Progress of residual inflammatory cardiovascular risk
10.16571/j.cnki.1008-8199.2020.07.017
- VernacularTitle: 残余炎性心血管风险的研究进展
- Author:
Xi-yang ZHOU
1
;
Chun-xiang TANG
1
;
Long-jiang ZHANG
1
;
Gui-fen YANG
2
Author Information
1. Department of Medical Imaging
2. Department of Nuclear Medicine, Jinling Hospital, Nanjing University School of Medicine/General Hospital of Eastern Theater Command, PLA, Nanjing 210002, Jiangsu, China
- Publication Type:Journal Article
- Keywords:
inflammation;
residual risk;
cardiovascular risk;
perivascular adipose tissue;
coronary heart disease
- From:
Journal of Medical Postgraduates
2020;33(7):760-764
- CountryChina
- Language:Chinese
-
Abstract:
Coronary artery disease (CAD) remains a leading cause of morbidity and mortality in the world. Although the comprehensive control of cardiovascular disease risk factors has achieved remarkable progress in recent years, the incidence of cardiovascular events is still high after the control of traditional risk factors such as low density lipoprotein cholesterol, blood pressure and blood glucose, collectively referred to as cardiovascular residual risk. Inflammation is a central driver of atherosclerosis and the ultimate rupture of plaque, as well as an important cause of residual cardiovascular risk. Therefore, this article reviews the formation, assessment and treatment of residual inflammatory cardiovascular risk.
